AstraZeneca’s latest purchase fails to impress investors
May 10, 2007Research and Development, Sales and Marketing
AstraZeneca has entered the lucrative vaccine market and gained a range of potential new biologic products with the $15.6 billion …
The End of the Junket?
May 10, 2007Medical Communications, Sales and Marketing ethics
Once considered a perk of the job by some doctors, trips to glamorous locations paid for by pharma companies are …
Scottish Sprycel approval turns spotlight on NICE
May 9, 2007Sales and Marketing Scotland
The Scottish Medicines Consortium has approved BMS leukaemia drug Sprycel, but patients in England could face a substantial wait for …
Take NHS away from politicians, say doctors
May 9, 2007Doctors have put together a list of radical reforms they say will stop the government undermining the NHS in England …
Product news roundup from Datamonitor
May 9, 2007Research and Development, Sales and Marketing
Additional indication for Pfizer's FragminThe FDA has approved a new indication for blood clot drug Fragmin to treat symptomatic venous …
EMEA gives extension to Celebrex’s European arthritis licence
May 4, 2007Sales and Marketing
Pfizer's Celebrex has received European approval for a new indication to treat arthritis pain and inflammation.The company will look to …
NHS must prepare for health impact of global warming, say experts
May 4, 2007Sales and Marketing
The British public and the NHS need to adapt to climate change and the new risks to health it will …
Herceptin approved for new breast cancer combination
May 4, 2007Sales and Marketing
Herceptin has gained approval in Europe for use in combination with aromatase inhibitor drugs.Herceptin and aromatase inhibitors each block hormones …
Generic attacks dent Sanofi-Aventis
May 4, 2007Sales and Marketing generics
Some of Sanofi-Aventis' biggest selling drugs came under assault from generic competitors in the first part of 2007, holding back …
Animal rights extremists arrested in nationwide raids
May 2, 2007Sales and Marketing animal activists
More than 30 suspected animal rights extremists have been arrested in raids across the UK and Europe in one of …
News update from Datamonitor
May 1, 2007Research and Development, Sales and Marketing
Common pain medications do not prevent Alzheimer's diseaseOver-the-counter pain medication naproxen and prescription pain reliever celecoxib do not prevent Alzheimer's …
Industry lobbies ministers ahead of OFT decision
May 1, 2007Sales and Marketing
The UK pharmaceutical industry is using a series of meetings with government ministers to push for a rejection of the …
Can pharma meet the generic challenge?
May 1, 2007Sales and Marketing generics, pharma, sales
The global pharmaceutical industry has generally been seen as one of the most successful industries in delivering revenue growth with …
Pharma news from Datamonitor
April 26, 2007Research and Development, Sales and Marketing
Gemin X compound effective in leukemiaGemin X has said its compound that treats acute lymphoblastic leukemia produced positive results in …
Product update from Datamonitor
April 26, 2007Research and Development, Sales and Marketing
Schering-Plough receives Japanese approval for ZetiaSchering-Plough has received Japanese marketing approval for Zetia, a cholesterol-lowering agent that inhibits the absorption …
Making Europe’s salesforces leaner and meaner
April 26, 2007Sales and Marketing Europe, representatives, sales, strategy
The world of pharma salesforce management is witnessing a serious move away from mass detailing to a system based on …
UK science at a ‘tipping point’
April 26, 2007Research and Development
The future for the UK's medical science base looks very bright, according to leading figures in the government, science and …
Januvia launched in UK
April 25, 2007Sales and Marketing Januvia, diabetes
Merck Sharp & Dohme has launched its first-in-class diabetes treatment Januvia in the UK. Januvia has been approved as an …
Free healthcare a ‘mirage’ in UK
April 25, 2007Sales and Marketing Doctors for reform
UK patients routinely top up their care by going private, undermining politicians’ claims the NHS is free-to-all, according to a …
Latest content
FibroFind appoints Lee Borthwick as CEO
